Search

for
Search:

GlossaryDiphenylcyclopropenone (DCP)

topical immunotherapy agent used to treat alopecia areata

Diphenylcyclopropenone (DPCP) is a topical immunotherapy agent used primarily to treat alopecia areata, a condition that causes hair loss. It works by inducing a mild allergic reaction on the scalp, which is thought to distract the immune system from attacking hair follicles, thereby promoting hair regrowth.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 116 results

research Efficacy and Tolerance of 2,3-Diphenylcyclopropenone in Propylene Glycol Versus Isopropanol for Treating Alopecia Areata

January 2017 in “Nasza Dermatologia Online”

Both treatments helped hair regrowth in alopecia areata, with isopropanol being better tolerated.

research Tropical Diphencyprone Therapy in Alopecia Totalis

5 citations , July 1988 in “British journal of dermatology/British journal of dermatology, Supplement”

Diphencyprone therapy can effectively treat severe hair loss in motivated patients.

research Alopecia Areata: Chronic Inflammatory Skin Disorder

1 citations , January 2015 in “Springer eBooks”

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

research Experimental Study on Dendrobium Candidum Polysaccharides on Promotion of Hair Growth

13 citations , January 2014 in “Zhongguo zhongyao zazhi”

Dendrobium candidum polysaccharides promote hair growth.

Possible Advantage of Imiquimod and Diphenylcyclopropenone Combined Treatment Versus Diphenylcyclopropenone Alone: An Observational Study of Nonresponder Patients With Alopecia Areata

research Possible Advantage of Imiquimod and Diphenylcyclopropenone Combined Treatment Versus Diphenylcyclopropenone Alone: An Observational Study of Nonresponder Patients With Alopecia Areata

9 citations , April 2016 in “Australasian journal of dermatology”

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

View more "dcp" in research →

Community Join

0 / 0 results

— no results